Search

Author/Creator Khalil, Ahmed F.

1. Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents. (31st December 2023)

Authors:
Khalil, Ahmed F.; El-Moselhy, Tarek F.; El-Bastawissy, Eman A.; Abdelhady, Rasha; Younis, Nancy S.; El-Hamamsy, Mervat H.
Journal:
Journal of enzyme inhibition and medicinal chemistry
Issue:
Volume 38:Number 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents. (31st December 2023)

Authors:
Khalil, Ahmed F.; El-Moselhy, Tarek F.; El-Bastawissy, Eman A.; Abdelhady, Rasha; Younis, Nancy S.; El-Hamamsy, Mervat H.
Journal:
Journal of enzyme inhibition and medicinal chemistry
Issue:
Volume 38:Number 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents. (31st December 2023)

Authors:
Khalil, Ahmed F.; El-Moselhy, Tarek F.; El-Bastawissy, Eman A.; Abdelhady, Rasha; Younis, Nancy S.; El-Hamamsy, Mervat H.
Journal:
Journal of enzyme inhibition and medicinal chemistry
Issue:
Volume 38:Number 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Effects of Dual Sofosbuvir/Daclatasvir Therapy on Weight and Linear Growth in Adolescent Patients with Chronic Hepatitis C Virus Infection. Issue 7 (July 2019)

Authors:
Yakoot, Mostafa; El-Shabrawi, Mortada H.; AbdElgawad, Manal M.; Mahfouz, Aml A.; Khalil, Ahmed F.; Kamal, Naglaa M.; Helmy, Sherine; Abdo, Alaa M.; Kamal, Enas M.; El-Khayat, Hisham R.
Journal:
Pediatric infectious disease journal
Issue:
Volume 38:Issue 7(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗